“Targets and Barriers for Hydroxyurea (HU) Therapy in Sickle Hemoglobinopathies,” is a six-site collaboration between five NYCON institutions, (Columbia University, Weill Cornell Medical College, Albert Einstein College of Medicine, University of Rochester, and Yale University) and University of California, San Francisco. Henry N. Ginsberg, MD (PI) and Nancy Green, MD (Co-PI) will lead this study focused on identifying novel indication for HU, pharmaco-genomic prediction of response, risks of and barriers to its use.

“Supplemental Funding for the Organic Synthesis Collaborative Center,” lead by Henry N. Ginsberg, MD (PI) and Donald W. Landry (Co-PI), aims to advance translational research by bolstering the Organic Synthesis Collaborative Center’s (OSCC) capacity to provide organic chemistry capabilities to biologically-oriented investigators and continue the successful acceleration of “bench-to-bedside” breakthroughs at CUMC.

“Amplifying the Pace of Collaborative and Multidisciplinary Pilot Research (CaMPR) at Columbia University” is a pilot project mechanism directed by Henry N. Ginsberg, MD (PI) and Nancy Reame, PhD (Co-PI), that will provide additional resources needed to expand the novel Collaborative and Multidisciplinary Pilot Research (CaMPR) award program.

“Advancing Institutional Efforts to Support Research Mentoring for Clinical/Translational Scientists” lead by Henry N. Ginsberg, MD (PI) and Harold A. Pincus, MD (Co-PI), aims to improve research workforce development and dissemination by providing institutional and program leaders with the information, guidance, and tools they need to evaluate and improve their research mentorship efforts.